Open navigation menu
Invest
Invest on your own
We do it for you
Halal tools
Screeners
Your portfolio
Calculators
Shariah
Our certifications
Learn
Education
Get help
News
Pricing
Company
About Musaffa
Investors
Build with us
Is Corcept Therapeutics Incorporated Stock Halal?
Shariah Compliance Analysis of CORT Stock
Yes. As of November 2026, Corcept Therapeutics Incorporated (CORT) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Corcept Therapeutics Incorporated passes Musaffa's business and financial screening criteria.
Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company is headquartered in Redwood City, California and currently employs 730 full-time employees. The company went IPO on 2004-04-15. The firm is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The company is also conducting advanced clinical trials in patients with solid tumors, Amyotrophic Lateral Sclerosis (ALS) and liver disease. The company operates through the discovery, development and commercialization of the pharmaceutical products segment. The company sells Korlym and a generic version of Korlym in the United States using sales representatives to call on physicians caring for patients with hypercortisolism (Cushing’s syndrome). The firm's portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. The company sells and distributes Lifyorli in the United States. The company is developing its proprietary, selective cortisol modulator, relacorilant, as a treatment for patients with hypercortisolism.
CORT Shariah Compliance
Screening Methodology: AAOIFI
As of November 2026, Corcept Therapeutics Incorporated is classified as halal.
HALALCorcept Therapeutics Incorporated (CORT) Chart
Fetching Price Chart...
Financial Metrics & Statements of Corcept Therapeutics Incorporated (CORT)
FAQ's for Corcept Therapeutics Incorporated (CORT)
- As of November 2026, Corcept Therapeutics Incorporated CORT is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Corcept Therapeutics Incorporated using these criteria to determine its compliance status.
- Muslim investors may consider investing in Corcept Therapeutics Incorporated if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Corcept Therapeutics Incorporated by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Corcept Therapeutics Incorporated may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Corcept Therapeutics Incorporated on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Corcept Therapeutics Incorporated (CORT)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.